MDM2 and osteosarcoma: Further evidence suggests that the MDM RING domain possesses oncogenic properties independent of p53, emphasizing the distinct structural and functional characteristics of the MDM2 and MDMX RING domains and characterizing their roles in osteosarcoma cell response by disrupting p53-dependent signaling pathways [42] (Figure 2).